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In spite of the therapeutic importance of endoderm derivatives such as the pancreas, liver, lung, and intestine, there are few molecular markers
specific for early endoderm. In order to identify endoderm-specific genes as well as to define transcriptional differences between definitive and
visceral endoderm, we performed microarray analysis on E8.25 definitive and visceral endoderm. We have developed an early endoderm gene
expression signature, and clarified the transcriptional similarities and differences between definitive and visceral endoderm. Additionally, we have
developed methods for flow cytometric isolation of definitive and visceral endoderm. These results shed light on the mechanism of endoderm
formation and should facilitate investigation of endoderm formation from embryonic stem cells.
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During early vertebrate development, formation of the three
germ layers (ectoderm, mesoderm, and endoderm) is one of the
first major events in specifying cell fates in the embryo. Since
embryonic stem (ES) cells are derived from and exhibit gene
expression and functional properties characteristic of pluripo-
tent embryonic cells, it is widely believed that directed
differentiation of ES cells into specific cell types for therapeutic
purposes will necessarily begin by inducing ES cells to form
germ layer intermediates.
Endoderm gives rise to pancreatic, hepatic, lung, intestinal
and other therapeutically relevant cell types, yet early endoderm
development is not well understood. Fate mapping studies of⁎ Corresponding authors.
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doi:10.1016/j.ydbio.2007.01.011cultured mouse embryos (Lawson et al., 1986, 1991; Lawson
and Pedersen, 1987) have revealed that definitive endoderm
begins to form at embryonic days 6–6.5 (E6–E6.5) and that by
the end of gastrulation (E7.5), some labeled cells only give rise
to endodermal derivatives. Heterotopic transplantation studies
have been carried out in zebrafish (David and Rosa, 2001) and
in Xenopus (Heasman et al., 1984; Wylie et al., 1987), and these
results demonstrate that by mid-to-late gastrulation, cells are
determined to give rise to endoderm. Whether mice and humans
have a similar time course for endoderm determination remains
to be determined.
It is not known whether the initial definitive endoderm cells
are multipotent. Fate mapping studies (Lawson et al., 1991;
Tremblay and Zaret, 2005) suggest that the first endoderm cells
that migrate through the primitive streak at E6.5 are fated to
become liver, ventral pancreas, lungs and stomach; later cells
become esophagus, stomach, dorsal pancreas, and duodenum;
and the last cells out become intestine. Several early
endodermal transcription factors, including Otx2, Hesx1, Hex,
and Cdx2, are regionally expressed prior to the time that organ
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1999). However, co-culture experiments show that the
endoderm in these regions is not fully committed at early
stages. For example, E7.5 mouse anterior endoderm co-
cultured with posterior mesoderm expresses markers of
posterior endoderm (Wells and Melton, 2000), posterior
transformations can occur after heterotopic transplantation of
anterior chick endoderm from 12–14 somite-stage embryos
(equivalent to ∼E8.5) (Kumar et al., 2003), and ventral
foregut endoderm explants from mouse 2- to 6-somite-stage
embryos (∼E8.25) can activate genes characteristic of the
pancreas, liver or lung depending on the mesodermal tissues
with which they are co-cultured (Deutsch et al., 2001; Serls et
al., 2005). Thus, while early endoderm is regionalized in
transcription factor expression as it migrates through the
primitive streak, some of these endoderm cells appear to be
capable of multilineage differentiation.
A complication in the study of endoderm is that mammals
possess extraembryonic endoderm. Extraembryonic endoderm
arises at the blastocyst stage and eventually forms two
subpopulations: visceral endoderm, the chief metabolic com-
ponent of the visceral yolk sac, and parietal endoderm, which
secretes Reichert's membrane and contributes to the transient
parietal yolk sac. Extraembryonic endoderm cells share the
expression of many genes with definitive endoderm (cells that
give rise to the endodermal organs), including the often
analyzed transcription factors Sox17 (Kanai-Azuma et al.,
2002), FoxA1 and FoxA2 (Belo et al., 1997; Sasaki and Hogan,
1993). In spite of their genetic similarity, lineage tracing
evidence combined with transplantation experiments suggest
that, as early as E3.5, cells are determined either to give rise to
extraembryonic endoderm or to give rise to the precursors of all
embryonic cell types, the pluripotent epiblast cells (Chazaud et
al., 2006; Kunath et al., 2005). The genetic pathways that
regulate cell fate determination of extraembryonic endoderm, as
well as genes that can serve as markers to distinguish definitive
and extraembryonic endoderm, are not understood.
Advances have been made in deriving endoderm from ES
cells, yet a better understanding of definitive and extra-
embryonic endoderm is necessary for the field to progress.
Recently, several groups have reported differentiation of mouse
or human ES cells into definitive endoderm (D'Amour et al.,
2005; Kubo et al., 2004; Tada et al., 2005; Yasunaga et al.,
2005); however, these reports rely on the expression of a
relatively small number of marker genes. In order to better
understand the distinction between definitive and extraembryo-
nic endoderm and to enable recognition of these populations
from differentiating ES cells, we undertook gene expression
profiling of E8.25 definitive and extraembryonic endoderm as
well as non-endodermal tissues at this developmental stage.
Previously, gene profiling of endoderm was performed
exclusively using E7.5 definitive endoderm and mesectoderm
(Gu et al., 2004). This did not permit a comparative analysis
between definitive and extraembryonic endoderm.
Here we also report on methods that allow for prospective
isolation of mouse definitive and extraembryonic endoderm.
Using these isolation techniques, we perform global geneexpression profiling on E8.25 definitive and extraembryonic
endoderm and define a gene expression signature for each
tissue. These results should facilitate the recognition, genetic
analysis, and testing of the developmental potential of embryo-
derived and ES cell-derived endoderm.
Materials and methods
Antibodies and immunostaining
The following primary antibodies were used: G8.8 (anti-EpCAM,
Developmental Studies Hybridoma Bank, Iowa City, IA); FE-J1 (Develop-
mental Studies Hybridoma Bank, Iowa City, IA); biotinylated SBA (Vector,
Burlingame, CA); biotinylated DBA (Vector, Burlingame, CA); APA5 (anti-
Pdgfra, ebioscience, San Diego, CA); Sox1 (Santa Cruz Biotechnology, Santa
Cruz, CA); Brachyury (Santa Cruz Biotechnology, Santa Cruz, CA); biotin anti-
CD106 (Vcam-1, BD Biosciences, San Jose, CA); PE anti-Flk1 (VEGFR2, BD
Biosciences, San Jose, CA); MC-813-70 (anti-SSEA-4, DSHB, Iowa City, IA);
Sox7 (Santa Cruz Biotechnology, Santa Cruz, CA); Cytokeratin-7 (Santa Cruz
Biotechnology, Santa Cruz, CA); Annexin IV (Santa Cruz Biotechnology, Santa
Cruz, CA); Sox17 (R+D Systems, Minneapolis, MN), YN1/1.7.4 (anti-Icam-1,
ebioscience, San Diego, CA), Ceacam-1 (Santa Cruz Biotechnology, Santa
Cruz, CA); Claudin-8 (Aviva Biosciences, San Diego CA), Desmoglein-2
(R&D Systems, Minneapolis, MN), FITC anti-Dpp4 (BD Biosciences, San
Jose, CA), biotin anti-CD38 (ebioscience, San Diego, CA), biotin anti-Tim-2
(ebioscience, San Diego, CA). Rhodamine Red-X, APC, PE, PE-Cy7, and
FITC-conjugated secondary antibodies (Jackson ImmunoResearch, West
Grove, PA) were used.
For immunostaining, whole-mount embryos or sections were blocked with
20% donkey serum and stained with primary antibody overnight at 4 °C. For
immunofluorescence, secondary antibody was added for 1 h at 25 °C, and for
immunohistochemistry, Vectastain EliteABC followed by DAB (Vector Labs,
Burlingame, CA) was used. Nuclei were visualized with Hoechst 33342
(Invitrogen, Carlsbad, CA). Photographs were taking using an LSM 510Meta
confocal microscope (Carl Zeiss, Inc., Germany) or a dissecting microscope
(Leica Microsystems, Germany).
Transgene construction and generation of Sox17-Venus transgenic
mice
Recombineered bacterial artificial chromosomes (BACs) were generated
(Yang and Seed, 2003). In brief, a kanamycin/neomycin-resistant template
vector was engineered encoding the yellow fluorescent protein Venus (Nagai
et al., 2002) (kindly provided by A. Miyawaki), followed by an SV40 poly A
site. Oligonucleotides were designed to amplify the template vector as well
as approximately 80 nucleotides of genomic sequence immediately preceding
the initial ATG of Sox17 (5′ oligo) and immediately following the 10th
nucleotide of Sox17 (3′ oligo) such that, upon recombination with a BAC,
the first 10 nucleotides of Sox17 coding region (all in exon 4) would be
replaced by the Venus-encoding gene and antibiotic resistance cassette. The
resulting amplicon was electroporated into induced bacteria harboring both a
Sox17-containing BAC (resistant to chloromycin) as well as 300 arabinose-
inducible recombinase components. Colonies resistant to kanamycin and
chloramphenicol were obtained, and successful recombination was confirmed
by PCR. BAC DNA was subsequently electroporated into mouse embryonic
stem cells, and neomycin-resistant colonies were obtained. Following PCR
confirmation of the BAC DNA, transgenic ES cells were injected into
blastocysts, and founder mice ultimately identified. Primers are listed in
Supplementary Table 1.
Tissue isolation and cell sorting
For all experiments, outbred ICR mice were used for breeding, and embryos
were considered to be E0.5 at noon of the day the plug was detected.
For manual endoderm isolation, E8.0–E8.25 definitive endoderm medial to
somites, spanning from anterior intestinal portal to unsegmented mesoderm, was
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Endoderms were pooled in groups of five and immediately transferred to
extraction buffer (XB) of the Arcturus RiboAmp kit for cRNA amplification.
Embryos to be used for flow cytometry were dissected in PBS and, when
noted, extraembryonic membranes were peeled from embryonic regions with
fine forceps. Embryos were proteolytically dissociated with 0.25% trypsin
(Invitrogen, Carlsbad, CA) or with 1 mg/ml papain (US Biological, Swampscott,
MA). For live cell sorting, antibody staining was performed in DMEM:F12+2%
FBS+ 10 mM EDTA for 20 min on ice. Before flow cytometric sorting, cells
were resuspended in staining buffer with calcein blue AM (Invitrogen, Carlsbad,
CA). For intracellular flow cytometric analysis, cells were fixed in PBS with 1%
paraformaldehyde and 0.01% Tween-20 (Sigma-Aldrich, St. Louis, MO) and
stained in PBS with 5% donkey serum and 0.05% Tween-20. Flow cytometric
sorting was performed using either a FACSAria (Becton Dickinson, San Jose,Fig. 1. Construction and endoderm-specific fluorescence of Sox17-Venus reporter m
endoderm composes a single-cell-thick layer on the outside of the cup-shaped embryo
cup, and visceral endoderm is above definitive endoderm. At E8.25, the foregut and
remains a single-cell-thick sheet. Visceral endoderm surrounds the embryo and is c
images of Sox17 antibody staining in E7.5 transverse section (B) and in E8.25 tran
known by fate mapping to be endodermal. (E) Schematics of the Sox17-Venus bacte
the BAC at which the construct integrated by homologous recombination. (F–H) Cry
Sox17 antibody staining (red in H). Venus fluorescence is found in endodermal regio
(G) and colocalizes with Sox17 protein in E7.5 transverse section (H, close-up of boxe
endoderm, NF=neural folds, HGEn=hindgut endoderm, No=notochord, VE=visceCA) or a MOFLO (Dako Cytomation, Carpinteria, CA), and data were analyzed
using DIVA software (Becton Dickinson, San Jose, CA).
cDNA Generation and hybridization to Affymetrix microarrays
Total RNA was isolated using TRIzol (Invitrogen, Carlsbad, CA) or
RiboAmp extraction buffer (Arcturus, Mountain View, CA). Target was
prepared from ≥50 ng of isolated RNA using the NuGEN WT-Ovation RNA
Amplification Kit (NuGen, San Carlos, CA) or RiboAmp RNA Amplification
Kit (Arcturus, Mountain View, CA) and hybridized to Affymetrix Mouse
Genome 430 2.0 GeneChips. All samples types were prepared as 3–6 biological
replicates. Data were analyzed using GenePattern software package (www.
broad.mit.edu/cancer/software/genepattern/) and Rosetta Resolver (Rosetta
Biosoftware, Seattle, WA).ice. (A) Diagrams of the germ layers in developing mouse embryos. At E7.5,
, surrounding mesoderm and ectoderm. The embryo composes the bottom of the
hindgut endoderm have begun to form a single-cell-thick tube, while the midgut
ontiguous with definitive endoderm. (B–D) Cryosection immunofluorescence
sverse sections (C: foregut, D: hindgut). Sox17 expression is found in regions
rial artificial chromosome (BAC) targeting construct (left) and the region within
osection immunofluorescence images of Venus (white in F–G; green in H) and
ns in both E7.5 longitudinal section (F, H) and E8.25 hindgut transverse section
d area on right). Ec=ectoderm, Me=mesoderm, En=endoderm, FGEn=foregut
ral endoderm.
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In situ hybridization was performed according to Wilkinson and Nieto
(1993). cDNAwas obtained from commercial clone libraries (Open Biosystems,
Huntsville, AL) and digoxigenin-labeled probes were generated. E8.25 and E9.5
embryos were fixed overnight in 4% paraformaldehyde, dehydrated in
methanol, bleached in hydrogen peroxide and treated with proteinase K,
followed by re-fixation. Probe was added at 1 μg/ml overnight at 70 °C.
Embryos were washed and labeled overnight with anti-digoxigenin–AP
antibody (Roche Applied Science, Indianapolis, IN). Embryos were developed
in BM Purple (Roche Applied Science, Indianapolis, IN).
Quantitative PCR
Quantitative PCR was carried out using the CellsDirect RNA isolation
system (Invitrogen, Carlsbad, CA) followed by Superscript III-mediated reverse
transcription (Invitrogen, Carlsbad, CA) and SYBR Green PCR (Invitrogen,
Carlsbad, CA). Flow cytometrically sorted cell populations were pelleted and
resuspended in CellsDirect buffer. PCR was performed in a MX3000p light
cycler (Stratagene, La Jolla, CA) up to 45 cycles, with 55 °C annealing
temperature. Primers used are listed in Supplementary Table 1. Expression
values were normalized to beta actin and GAPDH.
Embryonic stem cell culture
Undifferentiated mouse ES cells were maintained on gelatin-coated plates
with mouse embryonic fibroblast (MEF) feeders in DMEM (Invitrogen,
Carlsbad, CA) supplemented with 15% defined fetal bovine serum (FBS)
(HyClone, Logan, UT), 0.1 mM nonessential amino acids (Invitrogen, Carlsbad,
CA), Glutamax (Invitrogen, Carlsbad, CA), penicillin/streptomycin (Invitrogen,
Carlsbad, CA), 0.55 mM 2-mercaptoethanol (Sigma-Aldrich, St. Louis, MO),
5×105 units LIF (Chemicon, Temecula, CA).
Prior to differentiation, ES cells were passaged onto gelatin-coated plates for
45 min to deplete MEFs. MEF-depleted ES cells were then seeded at 106 cells/
5 ml/well of 6-well low cluster dishes for EB formation or seeded at∼2700 cells/
cm2 on gelatin-coated dishes for monolayer culture. Cells were allowed to settle
overnight and switched to differentiation media the following day following a
brief wash in phosphate-buffered saline. Differentiation was carried out for
7 days in DMEM (Invitrogen, Carlsbad, CA) supplemented with 5% defined
FBS, 0.1 mM nonessential amino acids (Invitrogen, Carlsbad, CA), Glutamax
(Invitrogen, Carlsbad, CA), penicillin/streptomycin (Invitrogen, Carlsbad, CA),
0.55 mM 2-mercaptoethanol (Sigma-Aldrich, St. Louis, MO), and 100 ng/ml
recombinant Activin A (R&D Systems, Minneapolis, MN), with fresh media
change every other day.
Results
Identification of endoderm by a Sox17-venus reporter mouse
In order to enable isolation of endoderm by methods distinct
from physical dissection, we developed a transgenic mouseFig. 2. Flow cytometric prospective isolation of endoderm. (A–B) Flow cytometric an
In E8.25 (A) and E9.5 (B) embryonic regions, cells that have highest expression of t
(C–E) Cryosection immunofluorescence images of EpCAM expression. In E7.5 tran
(Ec) but is absent from mesoderm (Me). In E8.25 transverse section (D), EpCAM
extraembryonic (VE) regions, weakly in ectoderm (NF) and notochord (No) and is ab
exclusively in the endodermally derived pharynx (PhEn), pancreas (PaEn) and inte
stained with soybean agglutinin (SBA, X-axis) and EpCAM (Y-axis). SBA stains a su
in E7.5 transverse section. SBA is restricted to the endoderm. (H–J) Combined extr
flow cytometric analysis. (H) In E8.25 embryonic regions, cells expressing the neur
population. (I–J) Sox1 expression in E7.5 embryonic regions is contained with
immunohistochemistry image of Pdgfra expression at E8.25. Staining is detected in
cytometric analysis of live, dissociated E8.25 embryonic cells stained with Pdgfra
expressing the lowest levels of EpCAM. Ec=ectoderm, Me=mesoderm, En=endo
No=notochord, VE=visceral endoderm, HMe=head mesenchyme, So=somitic mestrain with endoderm-specific fluorescence. We took advantage
of previous experimental evidence from Xenopus (Hudson et
al., 1997) and mouse (Kanai-Azuma et al., 2002) that indicates
that the transcription factor Sox17 is specifically expressed in
all early endoderm. Fate mapping experiments (Lawson et al.,
1991) demonstrate that both definitive and visceral endoderm
compose the external cell layer of the embryonic cup at E7.5
(diagrammed in Fig. 1A). At E8.25, definitive endoderm has
begun to form a tube of cells in the foregut and hindgut while
remaining a sheet of cells in the midgut, and visceral endoderm
forms a sheet of cells surrounding the embryo on all sides
(diagrammed in Fig. 1A). It was confirmed that Sox17 protein is
restricted to these endodermal regions at E7.5 (Fig. 1B) as well
as at E8.25 (Figs. 1C, D).
Thus, a transgenic mouse expressing the yellow fluorescent
protein variant Venus under the control of Sox17 regulatory
elements was created. A bacterial artificial chromosome
(BAC) containing the genomic region 86 kb upstream through
111 kb downstream of the Sox17 gene was engineered with
the first 10 nucleotides of Sox17 coding region replaced by a
Venus-containing construct (Fig. 1E). This construct was
electroporated into ES cells, chimeras were generated by
blastocyst injection, and Sox17 transgenic founders were
selected. Section immunofluorescence analysis of transgenic
embryos at E7.5 and E8.25 revealed fluorescence in definitive
and visceral endoderm (Figs. 1F, G), and Venus fluorescence
was confirmed to colocalize with Sox17 antibody staining in
cryosections (Fig. 1H).
Flow cytometric analysis of E8.25 Sox17-Venus embryos
proteolytically dissociated into a single cell suspension revealed
a higher fluorescence level in all cells as compared to non-
transgenic littermates, due to either ubiquitous low-level
expression of Sox17 or transgene leakiness; however, a Venus
(hi) subset could be distinguished (Supplemental Fig. 1). The
Venus(hi) population comprised between 5 and 15% of total
cells at all stages between E7.5 and E10.5 (data not shown), and
microarray analysis (see below) confirms that this Venus(hi)
population is highly enriched in Sox17 transcript compared to
Venus(lo) cells.
Prospective isolation of endoderm
We used the endoderm-enriched fluorescence of Sox17-
Venus transgenic mice to distinguish live early endoderm cellsalysis of live, dissected and dissociated Sox17-Venus transgenic embryonic cells.
he EpCAM antigen (Y-axis) display highest Sox17-Venus fluorescence (X-axis).
sverse section (C), EpCAM is expressed in endoderm (En) as well as ectoderm
is expressed strongly in endoderm of the foregut (FGEn), hindgut (HGEn) and
sent in mesoderm (Me). In E9.5 sagittal section (E), EpCAM (red) is expressed
stine (InEn). (F) Flow cytometric analysis of live, dissociated embryonic cells
bset of EpCAM(hi) cells. (G) Cryosection immunofluorescence analysis of SBA
acellular (H, I: EpCAM, Y-axis; J: SBA, Y-axis) and intracellular (Sox1, X-axis)
al-specific transcription factor Sox1 are exclusively found in the EpCAM(lo/−)
in EpCAM(hi) cells, but it is confined to SBA(−) cells. (K) Whole-mount
mesodermally derived head mesenchyme (HMe) and somites (So). (L) Flow
(X-axis) and EpCAM (Y-axis). Pdgfra expression is seen in the 40% of cells
derm, FGEn=foregut endoderm, NF=neural folds, HGEn=hindgut endoderm,
soderm.
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these cells. Antibodies and lectins that recognize cell surface
epitopes were screened by flow cytometry for enriched binding
to the Sox17-Venus(hi) definitive endoderm population in
embryos stripped of extraembryonic cells and proteolytically
dissociated into a single cell suspension. A monoclonal
antibody, G8.8, that recognizes the cell adhesion protein
EpCAM (Farr et al., 1991), was found to bind preferentially
to Venus(hi) cells at E8.25 (Fig. 2A) and to bind exclusively to
Venus(hi) cells at E9.5 (Fig. 2B). At early gastrulation stages
such as E6.5 and E7.5, EpCAM displays broader flow
cytometric expression, and EpCAM is expressed highly in
embryonic stem cells, which resemble blastula-stage epiblast
(data not shown).Fig. 3. Flow cytometric distinction of definitive and visceral endoderm. (A–C) Comb
E8.25 embryos. Sox7, a known extraembryonic endoderm-specific transcription facto
extraembryonic regions (which contain visceral endoderm) are dissected apart from ea
(C) yet only a small percentage of embryonic EpCAM(hi) cells (B). (D–E) Flow cyt
(DBA, X-axis) and EpCAM (Y-axis). Dissected E8.25 embryonic cells (D) do not exp
(E) express DBA. (F–G) Flow cytometric analysis of live, dissected cells stained with
not express SSEA-4, whereas nearly all dissected E8.5 extraembryonic EpCAM(hi) c
demonstrating DBA expression in visceral endoderm. (I) Section immunofluorescen
definitive foregut endoderm (FGEn) or hindgut endoderm (HGEn). (I) E8.25 who
visceral endoderm. (J) Section immunofluorescence image demonstrating SSEA-4
(FGEn) or hindgut endoderm (HGEn). Me=mesoderm, FGEn=foregut endoderm
endoderm.The endoderm-enriched binding of EpCAM at E8.25 and E9.5
but not at E7.5 was confirmed by section immunofluorescence
analysis. EpCAM expression is strong in both ectoderm and
endoderm at E7.5 (Fig. 2C) 4 and becomes weaker in
neuroectoderm by E8.25 (Fig. 2D), and EpCAM expression is
exclusive to endoderm at E9.5 (Fig. 2E). EpCAM remains
strongly expressed in most endodermal cells until at least E12.5
(data not shown). Thus, EpCAM allows prospective isolation of
endoderm at and after E8.25.
To permit prospective isolation of endoderm at stages earlier
than E8.25, dissociated embryonic regions of E7.5 embryos
were further screened by flow cytometry for antibodies or
lectins that recognize a subset of EpCAM(hi) cells. The lectin
soybean agglutinin (SBA) recognizes 10% of all E7.5 cells,ined extracellular (EpCAM) and intracellular (Sox7) flow cytometric analysis of
r, stains a subset of EpCAM(hi) cells in whole embryos (A). When embryonic ad
ch other, Sox7 reactivity is present in nearly all extraembryonic EpCAM(hi) cells
ometric analysis of live, dissected cells stained with dolichos biflorus agglutinin
ress DBA, whereas nearly all dissected E8.25 extraembryonic EpCAM(hi) cells
SSEA-4 (X-axis) and EpCAM (Y-axis). Dissected E8.25 embryonic cells (F) do
ells (G) express SSEA-4. (H) E8.25 whole-mount immunohistochemistry image
ce image demonstrating DBA expression in visceral endoderm (VE) but not in
le-mount immunohistochemistry image demonstrating SSEA-4 expression in
expression in visceral endoderm (VE) but not in definitive foregut endoderm
, NF=neural folds, HGEn=hindgut endoderm, No=notochord, VE=visceral
Table 1
Endoderm-enriched transcription factors
All endoderm enriched Definitive endoderm
enriched (>2-fold)
Visceral endoderm
enriched (>3-fold)
5730467H21Rik Dlx3 Cited1
Foxa1 Dlx5 Foxa3
Ripk4 Foxg1 Hnf4A
Sox17 Gata3 Irf6
Idb4 Nfatc2
Pax9 Npas2
Sp6 Tcf2
Trp63 Vdr
Transcripts characterized by gene ontology as possessing transcription factor
activity that are enriched >2-fold in definitive endoderm and/or >3-fold in
extraembryonic endoderm than in all other microarray sample groups are listed
according to their expression pattern.
Table 2
Non-endoderm-enriched transcription factors that distinguish definitive and
visceral endoderm
Definitive endoderm
enriched (>3-fold)
Visceral endoderm
enriched (>3-fold)
Arnt2 Hoxb9 Pax6 Asb8 Nfatc1
Cdx4 Hoxc4 Pax8 Atp6v0a1 Nfe2l2
Cutl2 Hoxc8 Pbx1 Ehf NfIa
Dlx2 Hoxd1 Pknox2 Elf1 Pcbd
Dmrta1 Hoxd8 Rfx3 Foxf1A Ppargc1a
Evx1 Hoxd9 Six1 Foxq1 Runx1
Foxc1 Irx2 Six3 Gata4 Sec14l2
Foxc2 Irx3 Sox11 Gata6 Sox7
Gli3 Irx5 Sox21 Hoxb8 Stat5a
Hey2 Isl1 Sox9 Ipf1 Stat5b
Hoxa1 Meox1 Ssbp2 Irf2bp2 Tcf19
Hoxa3 Morf4lp1 T Irf6 Tfec
Hoxa9 Mrg1 Tcfap2a Lass2 Twist1
Hoxb1 Nkx1-2 Tcfap2b Lhx1
Hoxb2 Pax1 Tpbg
Hoxb3 Pax3 Zhx2
Transcripts characterized by gene ontology as possessing transcription factor
activity that are enriched or depleted >3-fold in definitive endoderm as
compared to extraembryonic endoderm but that are additionally expressed in
other microarray sample groups are listed according to their expression pattern.
547R.I. Sherwood et al. / Developmental Biology 304 (2007) 541–555virtually all EpCAM(hi) ectoderm/endoderm cells (Fig. 2F).
Flow cytometric analysis at later stages reveals that SBA
colocalizes with EpCAM(hi) endoderm at E8.25 and E9.5 as
well (Supplemental Fig. 2). Section immunofluorescence
demonstrates that SBA is exclusively expressed in endoderm
at E7.5 and E8.25 (Fig. 2G and Supplemental Fig. 2).
Interestingly, the monoclonal antibody FE-J1 (Fenderson et
al., 1984) has a similar flow cytometric and immunofluores-
cence profile at E7.5 and E8.25 but is expressed by very few
cells in the E9.5 embryo (Supplemental Fig. 2).
As further proof that EpCAM at E8.25 and SBA at E7.5
allow flow cytometric isolation of endoderm, their expression
was compared to markers of neuroectoderm and mesoderm.
Intracellular flow cytometric analysis of fixed E8.25 embryonic
cell suspensions confirms that the neuroectodermal marker
Sox1 (Wood and Episkopou, 1999) is expressed in a subset of
EpCAM(lo/−) cells but not in EpCAM(hi) endoderm (Fig. 2H).
Unfortunately, the fixation required for intracellular flow
cytometric analysis prevents resolution of EpCAM(lo) and
EpCAM(−) subsets. At E7.5, Sox1-expressing cells comprise a
subset of EpCAM(hi) cells but are mutually exclusive with
SBA-expressing endoderm (Figs. 2I, J). Similarly, flow
cytometric co-staining of live, E8.25 embryonic cell suspen-
sions with EpCAM and Pdgf receptor alpha (Pdgfra), which is
expressed in all E7.5–E8.25 non-notochordal mesoderm (Orr-
Urtreger et al., 1992) demonstrates that Pdgfra is exclusively
and uniformly expressed in the EpCAM(−) fraction (Fig. 2L).
Not only does this finding lend support to the idea that EpCAM
is expressed most strongly in endoderm at E8.25, it gives insight
into the nature of EpCAM(lo) cells (see Fig. 2A). The E8.25
EpCAM section immunofluorescence analysis (Fig. 2C) shows
dim expression in neural cells yet no expression in non-
notochordal mesodermal cells. The flow cytometric co-staining
of EpCAM and Pdgfra (Fig. 2L) shows that all EpCAM(−) cells
express the mesodermal Pdgfra. Thus, it is evident that
expression of EpCAM alone distinguishes non-notochordal
mesoderm as EpCAM(−), neuroectoderm and notochord as
EpCAM(lo) and endoderm as EpCAM(hi) at E8.25. Thus, using
EpCAM at E8.25 and later or SBA or FE-JI at E7.5, definitive
endoderm can be prospectively distinguished from other germ
layer derivatives.Prospective distinction of definitive and visceral endoderm
The analysis above demonstrates that, in embryos dissected
away from extraembryonic components, definitive endoderm
can be distinguished from the other germ layers based on cell
surface epitopes. However, as previously stated, mice possess
extraembryonic endoderm as well as definitive endoderm, and
these tissues co-express many genes including Sox17.
Thus, we sought to find epitopes that allow for distinction of
live definitive and extraembryonic endoderm. We focused on
distinguishing definitive and visceral endoderm and not parietal
endoderm because visceral endoderm is morphologically more
similar to definitive endoderm. To confirm that both definitive
and visceral endoderm can be identified flow cytometrically by
EpCAM expression, as expected by immunofluorescence (Fig.
2C), dissociated E8.25 whole embryo, dissected embryonic
tissues, or dissociated extraembryonic tissues were co-stained
with EpCAM and the extraembryonic endoderm-specific
transcription factor Sox7 (Kanai-Azuma et al., 2002). In the
whole embryo, Sox7 was expressed in a subset of EpCAM(hi)
cells (Fig. 3A), which comprised few embryonic EpCAM(hi)
cells (Fig. 3B) and nearly all extraembryonic EpCAM(hi) cells
(Fig. 3C). Thus, EpCAM marks both definitive and visceral
endoderm.
Next, antibody and lectin screening was performed to
identify epitopes expressed at different levels in definitive and
visceral endoderm. This analysis revealed that dolichos biflorus
lectin (DBA) and SSEA-4 were both flow cytometric markers of
visceral endoderm. DBA and SSEA-4 expression were,
similarly to Sox7, not found in embryonic EpCAM(hi) cells
but found at high levels in extraembryonic EpCAM(hi) cells
(Figs. 3D–G). The flow cytometric profiles of DBA and SSEA-
4 were confirmed by whole-mount immunohistochemistry and
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largely confined to visceral endoderm (Figs. 3H–K). Thus, from
E8.25 whole embryos, definitive endoderm can be prospec-
tively isolated as EpCAM(hi)DBA(−)SSEA-4(−) and visceral
endoderm as EpCAM(hi)DBA(+)SSEA-4(+).
Microarray analysis of E8.25 tissues
The ability to isolate definitive and visceral endoderm as
well as mesoderm and neuroectoderm/notochord permitted
global gene expression analysis of these tissues. Thus,
microarrays were performed on E8.25 (2–8 somites) embryo-
nic and extraembryonic tissues using three different isolation
techniques. In the first approach, E8.25 midgut and hindgut
definitive endoderm was micro-dissected away from mesecto-
derm. In the second approach, whole embryo (definitive and
visceral) Sox17-Venus(hi) endoderm and Sox17-Venus(lo)
mesectoderm were flow cytometrically isolated. In the third
approach, dissected and sorted extraembryonic EpCAM(hi)
DBA(+) visceral endoderm, extraembryonic EpCAM(−)
DBA(−) yolk sac mesoderm, embryonic EpCAM(hi)DBA(−)
definitive endoderm, embryonic EpCAM(lo)DBA(−) neuroec-
toderm/notochord, and embryonic EpCAM(−)DBA(−) meso-
derm were isolated from E8.25 embryos. Undifferentiated ES
cells were also profiled as a control. In all cases, 3–6
biological replicates of amplified cDNA were hybridized to
Affymetrix 430_2 microarrays.
In order to confirm the validity of the microarray results,
microarray foldchange values of well-characterized marker
genes were analyzed. Genes known to be expressed in all
endoderm [Sox17 (Kanai-Azuma et al., 2002), FoxA1 (Ang et
al., 1993)], visceral endoderm [Hnf4a (Duncan et al., 1994) and
Amn (Kalantry et al., 2001)], definitive endoderm and
notochord (Shh (Echelard et al., 1993)), notochord (T (Wilk-
inson et al., 1990)), neuroectoderm [Sox1 (Wood and
Episkopou, 1999) and Pax6 (Walther and Gruss, 1991)],
mesoderm [Pdgfra (Orr-Urtreger et al., 1992), Meox1 (Candia
et al., 1992), and Tbx5 (Chapman et al., 1996)], and yolk sac
mesodermal hematopoietic progenitors [Gata1 and Tal1 (Silver
and Palis, 1997)] were upregulated in the expected populations
(Supplemental Fig. 3). Also of note, CXCR4, a gene utilized to
isolate endoderm from differentiating mouse and human ES
cells (D'Amour et al., 2005; Yasunaga et al., 2005), is expressed
equally strongly in definitive endoderm, neuroectoderm/noto-Fig. 4. Confirmation of microarray-enriched visceral endoderm-specific cell surface p
of visceral endoderm-enriched cell surface proteins. Flow cytometric analysis of live
EpCAM (Y-axis) and Dpp4 (A–B), CD38 (D–E), or Ceacam1 (G–H) on the X-axis.
Section immunofluorescence images demonstrating expression of Dpp4 (C), CD38
endoderm (FGEn) or hindgut endoderm (HGEn). (G–L) Whole-mount in situ hyb
endoderm-specific staining in E8.25 foregut (J, M), E8.25 hindgut (K, N) and E9.5
(black), visceral endoderm (blue), definitive endoderm (red) and mesoderm/neuroec
can be distinguished in embryos and some in cultures of differentiating ES cells. (
understanding early endoderm specification. The microarrays reveal two classes of
Sox17, FoxA1, Ripk4, and 5730467H21Rik, and an “extraembryonic endoderm cass
both extraembryonic and definitive endoderm requires induction of the “endoderm i
endoderm specification requires induction of the “extraembryonic endoderm cassette
HGEn=hindgut endoderm, No=notochord, VE=visceral endoderm.chord and mesoderm although expression is significantly
weaker in extraembryonic tissues (Supplemental Fig. 4),
suggesting that its utility derives primarily in distinguishing
embryonic and extraembryonic tissues and not in recognizing
endoderm. Other genes used as markers for endoderm in
differentiated ES cells such as MixL1, Gsc, T, Cer1, and Hhex
[(D'Amour et al., 2005; Kubo et al., 2004; Tada et al., 2005;
Yasunaga et al., 2005)] were not found to be expressed at higher
levels in E8.25 definitive endoderm than in non-endodermal
tissues (Supplemental Table 1).
The profiling of definitive and visceral endoderm afforded
an opportunity to analyze the transcriptional regulatory simi-
larities and differences between these tissues. From a gene
ontology (GO) search, only four transcription factors were
expressed >2-fold higher in definitive endoderm and >3-fold
higher in visceral endoderm than any other comparison tissue
(Table 1). For these four transcription factors, Sox17 is known
to be essential for endoderm formation and maintenance
(Kanai-Azuma et al., 2002), FoxA1 is a member of the
HNF3 family that is also vital in endoderm formation and
maintenance (Dufort et al., 1998), Ripk4 is not essential for
endoderm formation but is necessary for proper morphogenesis
of the oral, nasal, anal, and esophageal endoderm (Holland et
al., 2002), and the role of 5730467H21Rik is unknown
(expression analysis confirming endoderm-specific expression
of Ripk4 and 5730467H21Rik is presented below).
In addition to these four pan-endodermal transcription
factors, transcription factors expressed exclusively in either
definitive or visceral endoderm were analyzed. The 10 trans-
cription factors expressed >2-fold higher in definitive endoderm
than in any other tissue (Table 1) all have known expression
patterns at E8.25 and are involved in components of pharyngeal
endoderm organogenesis—none of these genes is pan-endoder-
mal. Four of the eight transcription factors expressed >3-fold
higher in visceral endoderm than in all other tissues (Irf5, Nfatc2,
Npas2, Vdr; Table 1) are previously uncharacterized. Of the
characterized genes, Hnf4a (Chen et al., 1994) and Tcf2
(Barbacci et al., 1999; Coffinier et al., 1999) are necessary for
visceral endoderm formation, Cited1 is necessary for proper
extraembryonic development (Rodriguez et al., 2004), and
FoxA3 is a member of the HNF3 family, which is necessary for
visceral endoderm formation (Ang and Rossant, 1994).
A further comparison on transcription factors not exclusive to
endoderm was performed, detecting transcriptional differencesroteins and models of endoderm identification and specification. (A–I) Analysis
, dissected embryonic (A, D, G) and extraembryonic (B, E, H) cells stained with
All antibodies display specific staining of extraembryonic (visceral) endoderm.
(F) and Ceacam1 (I) in visceral endoderm (VE) but not in definitive foregut
ridization analysis of Ripk4 (J–L) and Rbm35a (M–O). Both probes display
gut (L, O). (P) Diagram displaying cell surface epitope expression in ES cells
toderm (green). Using combinations of these markers, all of the listed cell types
Q) Diagram depicting the implications of the microarrays of E8.25 tissues on
transcriptional regulatory groups, an “endoderm identity” group containing of
ette” containing Hnf4a, Tcf2, Cited1, Gata4, Gata6, and others. Specification of
dentity” group, yet specification of extraembryonic endoderm but not definitive
.” Details in text. Me=mesoderm, FGEn=foregut endoderm, NF=neural folds,
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Table 3
Characterization of “endoderm signature” candidate genes
Endoderm signature genes
mRNA/Protein
localization
verified as
endoderm-
enriched?
Expressed
>2-fold higher
in embryonic
EpCAM(hi)DBA(−)
vs. ES cells?
qPCR
confirmation of
definitive
endoderm
enrichment over
mesectoderm
E7.5 E8.25 E9.5
Previously confirmed endoderm-enriched genes
Emb Yes
(Sousa-Nounes
et al. 2003)
Yes ND ND ND
FoxA1 Yes
(Monaghan
et al. 1993)
Yes ND ND ND
Sox17 Yes
(Kanai-Azuma
et al. 2002)
Yes ND ND ND
Tacstd1 Yes (AB) No ND ND ND
Novel E7.5–E9.5 “endoderm signature” genes
5730521E12RIK Yes (ISH) Yes Yes Yes Yes
AnxA4 Yes (AB) No Yes Yes Yes
Bnipl Yes (ISH) No Yes Yes Yes
Cacna1b Yes (ISH) Yes Yes Yes Yes
Cdcp1 Yes (ISH) Yes Yes Yes Yes
Cldn8 Yes (AB) Yes Yes Yes Yes
Clic6 Yes (ISH) Yes Yes Yes Yes
Dsg2 Yes (AB) No Yes Yes Yes
Krt2-7 Yes (AB) Yes Yes Yes Yes
Npnt Yes (ISH) Yes Yes Yes Yes
Rab15 Yes (ISH) Yes Yes Yes Yes
Rbm35a Yes (ISH) No Yes Yes Yes
Ripk4 Yes (ISH) Yes Yes Yes Yes
Sh3gl2 Yes (ISH) No Yes Yes Yes
Spink3 No (untested) Yes Yes Yes Yes
St14 Yes (ISH) No Yes Yes Yes
Tmem30b No
(noworking probe)
Yes Yes Yes Yes
Tmprss2 Yes (ISH) Yes Yes Yes Yes
E8.25 endoderm-enriched genes not enriched at all early embryonic timepoints
5730467H21RIK Yes (ISH) Yes No Yes Yes
Crb3 No
(noworking probe)
No Yes Yes No
Dpp4 No (untested) Yes Yes No Yes
Ell3 Yes (ISH) No No Yes Yes
Gprc5c Yes (ISH) Yes No No Yes
Prss8 No (untested) Yes No No Yes
Genes not enriched in E8.25 endoderm
Igfbp5 No (ISH) Yes ND ND ND
Spint1 No (ISH) No ND ND ND
Tmprss13 No (untested) Yes No No No
Summary of microarray expression, expression pattern at E8.25, and quan-
titative PCR (qPCR) expression data for 31 genes enriched in microarrays of
E8.25 endodermal cells as compared to those of non-endodermal cells. Refer to
text for explanation of microarray experimental design. Genes are categorized
by their spatial expression as determined by in situ hybridization or antibody
staining as well as by their comparative qPCR expression in sorted definitive
endoderm vs. mesectoderm cells at E7.5, E8.25 and E9.5. Eighteen genes
(5730521E12Rik, AnxA4, Bnipl, Cacna1b, Cdcp1, Cldn8, Clic6, Dsg2, Krt2-7,
Npnt, Rab15, Rbm35a, Ripk4, Sh3gl2, St14, and Tmprss2) were newly found to
be endoderm enriched by all criteria tested.
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expressed >3-fold higher in definitive than visceral endoderm
but also expressed in non-endodermal tissues included 12
homeobox family transcription factors (HoxA1, HoxA3,
HoxA9, HoxB1, HoxB2, HoxB3, HoxB9, HoxC4, HoxC8,
HoxD1, HoxD8, HoxD9) and members of other homeobox
families involved in embryonic patterning such as paired (Pax1,
Pax3, Pax6, Pax8, Pax9), distal-less (Dlx2), Iroquois related
(Irx2, Irx3, Irx5), sine oculis-related (Six1, Six3) and SRY-box
containing (Sox9, Sox11, Sox21) (Table 2). Transcription
factors expressed >3-fold higher in visceral than definitive
endoderm but also expressed in non-endodermal tissues
included only one homeobox transcription factor (HoxB8) but
contained transcription factors such as Gata4, Gata6, Lhx1, and
Sox7 that are implicated in endoderm formation in lower
vertebrates (Table 2).
An additional GO search was performed on plasma
membrane proteins, expanding the list of cell surface proteins
allowing prospective isolation of visceral endoderm. Plasma
membrane-localized genes upregulated >3-fold in visceral
endoderm as compared to all other tissues were identified by
GO search. Five candidates from this in silico analysis, Icam1,
Ceacam1, Dpp4, CD38 and Timd2, were confirmed to be
visceral endoderm-enriched at E8.25 by flow cytometry (Figs.
4A–B, D–E, G–H, data not shown) and section immunofluor-
escence (Figs. 4C, F, I, data not shown). Notably, Icam1, CD38,
and Timd2 are also expressed in undifferentiated ES cells,
whereas Ceacam1 and Dpp4 are not (data not shown). This
analysis expands the list of cell surface epitopes that
prospectively distinguish visceral endoderm from all other
cells in the E8.25 embryo.
A pan-endodermal signature
A more global analysis of the data was performed to identify
endoderm-enriched transcripts and to devise a signature of
genes that characterize early endoderm. Since the transcrip-
tional analysis suggested that the vital definitive endoderm
transcription factors are also expressed in visceral endoderm,
the signature was designed to find genes overexpressed in
definitive endoderm versus non-endodermal tissues and not to
exclude visceral endoderm expression. Thirty-one genes that
were enriched >2-fold in dissected definitive endoderm, in
sorted Sox17Venus(hi) endoderm and in embryonic EpCAM
(hi)DBA(−) definitive endoderm as compared to all other non-
endodermal tissues were chosen for further examination as
“endoderm signature” genes (Table 3). Three such genes, Sox17
(Kanai-Azuma et al., 2002), FoxA1 (Ang et al., 1993;
Monaghan et al., 1993), and Embigin (Huang et al., 1990;
Sousa-Nunes et al., 2003) have already been shown to have
exclusive endodermal expression at E7.5–E9.5, and a fourth,
Tacstd1 is the epitope recognized by EpCAM and has been
confirmed by this work to be upregulated in endoderm.
The remaining 27 genes were analyzed for their endoderm
specificity at multiple developmental stages. Quantitative PCR
(qPCR) was performed on flow cytometrically isolated
definitive endoderm and mesectoderm at E7.5, E8.25 and
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performed at E8.25 and E9.5. It was found that 16 of these genes
(5730521E12Rik, AnxA4, Bnipl, Cacna1b, Cdcp1, Cldn8,
Clic6, Dsg2, Krt2-7, Npnt, Rab15, Rbm35a, Ripk4, Sh3gl2,
St14, and Tmprss2) were highly enriched in endoderm by in situ
hybridization or antibody staining at E8.25 and E9.5 and were
significantly enriched in definitive endoderm as compared to
mesectoderm by qPCR at E7.5, E8.25 and E9.5 (Figs. 4J–O,
Supplemental Fig. 5, summarized in Table 3). An additional two
genes (Spink3 and Tmem30b) were confirmed by qPCR at all
stages but were unable to be detected by in situ hybridization
(Table 3). The expression patterns reveal that all of these genes
are expressed in both definitive and visceral endoderm. Of the
other nine endoderm signature candidates, six (5730467H21Rik,
Crb3, Dpp4, Ell3, Gprc5c, Prss8) were enriched in endoderm by
qPCR at some but not all developmental stages tested, two
(Igfbp5 and Spint1) were determined by in situ hybridization to
be expressed strongly not only in endodermal regions but in
other germ layers (Supplemental Fig. 5), and one (Tmprss13)
was not enriched in endoderm by qPCR at any stage (Table 3).
Thus, we have identified a set of 22 genes, only three of which
were previously known to be endoderm-enriched, which are
expressed preferentially in definitive and visceral endoderm
throughout early development and can collectively be used as an
“endoderm signature.”
Application in differentiating embryonic stem cells
To determine the utility of the cell surface proteins and
marker genes identified in this work for studies on ES cell
differentiation, mouse ES cells were induced to differentiate
in monolayer culture or as embryoid bodies (EBs) and were
assessed after 7 days of differentiation. Some samples were
treated with activin A to induce endoderm formation (Kubo et
al., 2004; Yasunaga et al., 2005). Undifferentiated and
differentiated samples were stained with antibodies against
EpCAM, CD38, and Dpp4, which in E8.25 embryos
distinguish definitive endoderm (EpCAM+CD38−Dpp4−),
visceral endoderm (EpCAM+CD38+Dpp4+), and mesecto-
derm (EpCAM−CD38−Dpp4−) and should also allow distinc-
tion of undifferentiated ES cells (EpCAM+CD38+Dpp4−) (see
Fig. 4P).
As expected, >97% of undifferentiated ES cells were
EpCAM+, CD38+, and Dpp4− and induction of differentiation
revealed populations with the surface marker expression profile
characteristic of definitive endoderm, visceral endoderm and
mesectoderm (Fig. 5A). EpCAM+Dpp4+ cells, presumed to be
visceral endoderm, were nearly absent in cultures differentiated
in monolayer, whereas EBs possessed ∼4% EpCAM+Dpp4+
cells, a percentage that was significantly reduced by activin
treatment (Fig. 5A). In both monolayer and EB differentiation,
between 10 and 30% of cells became EpCAM+CD38−,
presumed to be definitive endoderm. Activin increased the
percentage of these cells in EBs but not monolayer culture
(Fig. 5A).
To further investigate endoderm induction from ES cells,
qPCR analysis was performed on differentiating ES cells usingsix pan-endodermal genes (Cdcp1, FoxA1, Npnt, Rab15,
Ripk4, Tmprss2) as well as six genes specifically expressed in
visceral endoderm in the microarray analysis (Afp, Amn, Hnf4a,
Npas2, Slc13a4, and Tcf2). Induction of differentiation in
monolayer and EBs led to a strong induction of most pan-
endodermal genes (6/6 genes in monolayer, 5/6 genes in EB;
Supplemental Fig. 6). Activin treatment enhanced the induction
of most of these pan-endodermal genes (5/6 genes for
monolayer and EB; Fig. 5B), although this enhancement was
modest in degree (1.9-fold in monolayer, 1.6-fold in EB; Fig.
5B). Thus, the “endoderm signature” genes do serve as useful
markers of ES cell-derived endoderm induction. Induction of
visceral endoderm transcripts, however, was dependent on
culture mode: in monolayer differentiation, visceral endoderm
gene expression was significantly reduced, whereas such
expression was significantly increased in EB differentiation,
although activin prevented this increase (Fig. 5B).
To determine whether the cell surface markers utilized
accurately reflect production of definitive and visceral endo-
derm, a statistical correlation analysis was performed. The
percentage of cells in each culture condition possessing a
visceral endoderm surface marker profile (EpCAM+CD38+
Dpp4+) or a definitive/visceral endoderm surface marker profile
(EpCAM+CD38−Dpp4− or EpCAM+CD38+Dpp4+) was
plotted against the average level of expression of visceral
endoderm or pan-endodermal genes (Figs. 5C–D). The results
strikingly showed a nearly perfect correlation (0.988 correlation
coefficient) between visceral endoderm cell surface marker
expression and gene expression (Fig. 5C), while they revealed
weak correlation (0.389 correlation coefficient) between all
endoderm cell surface marker expression and gene expression
(Fig. 5D). These results imply that the cell surface markers
discovered to be uniquely expressed in E8.25 visceral endoderm
serve as an accurate proxy for ES cell visceral endoderm
induction; however, additional markers will need to be
identified to allow for pure prospective distinction of definitive
endoderm from ES cells.
Discussion
The potential therapeutic application of ES cell-derived cell
types and organs has received much attention in recent years.
While random differentiation of ES cells in EBs or in teratomas
yields a variety of differentiated cell types, this approach has
thus far failed to allow efficient generation of specific cell types.
On the other hand, recapitulation of developmental signaling
and transition through developmentally relevant cell type
intermediates has been shown to permit efficient generation of
mature, functional cell types (Wichterle et al., 2002). Whether
ES cells have the capacity to differentiate into cell types that
closely resemble early embryonic populations such as definitive
endoderm is unknown in part because the embryonic equiva-
lents have not been sufficiently characterized. Thus, it was the
goal of this report to define the transcriptional pattern of early
definitive and visceral endoderm and utilize this information to
provide a signature with which to identify endoderm derived
from ES cells.
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and visceral endoderm, the most striking observation is the
shared transcriptional regulation of definitive and visceral
endoderm. Both endoderm samples share expression of the
key endoderm regulators Sox17 and FoxA1 as well as of thenewly characterized Ripk4 and 5730467H21Rik. However,
whereas the transcription factors expressed in E8.25 visceral
but not definitive endoderm, including Hnf4a, Tcf2, Cited1,
Gata4, and Gata6 are crucial for its formation and metabolic
function (Bielinska et al., 1999), the transcription factors
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been demonstrated to act in the endoderm organogenesis
process, and a role for such transcription factors in formation
of definitive endoderm has not yet been demonstrated.
Visceral endoderm thus shares an “endoderm identity” gene
expression cassette with definitive endoderm but contains an
additional cassette of transcription factors that regulates its
formation and nutritive function in the embryo (Fig. 4Q).
These data lead to the question of the evolution of
extraembryonic endoderm. The pan-endodermal Sox17 and
Hnf3 factors play crucial roles in endoderm development in
frogs and zebrafish, but in these species, these factors act
downstream of GATA factors (Shivdasani, 2002). In mice,
GATA4 and GATA6 are expressed in E8.25 visceral but not
definitive endoderm, suggesting that some components of the
transcriptional networks controlling endoderm formation are
active in extraembryonic but not definitive endoderm forma-
tion. Interestingly, many genes in this “extraembryonic
endoderm cassette” are expressed later in development in the
liver, intestine and pancreas and regulate metabolism in the
mature organism. It is enticing to speculate that this
extraembryonic endoderm cassette reflects an evolutionarily
ancient metabolic regulation system whose expression has
been transferred to extraembryonic endoderm in early
mammalian embryos.
The common transcriptional machinery in definitive and
visceral endoderm implies a similarity in the mechanism of
specification of the two tissues. Even though specification and
cell fate commitment of extraembryonic endoderm occurs
during the early blastocyst stage (∼E3.5; Chazaud et al., 2006;
Kunath et al., 2005), and specification of definitive endoderm
occurs during gastrulation (∼E6.5), it is enticing to consider
that common signaling events induce Sox17 and the HNF3
genes. These signaling events confer “endoderm identity,” and
extraembryonic endoderm induction presumably involves
additional signaling events that induce its “extraembryonic
endoderm cassette.”
This line of reasoning implies that selective induction of
definitive endoderm from ES cells may require inhibition of
visceral endoderm. Thus, factors promoting endoderm forma-
tion such as those of the Nodal family (Feldman et al., 1998,
Tremblay et al., 2000) should be combined with factors that
inhibit induction of the extraembryonic endoderm cassette to
specifically induce definitive endoderm. Such extraembryonic
endoderm-promoting factors are for the most part unknown,
although analysis of mutants has recently suggested an
involvement of the FGF signaling pathway (Chazaud et al.,
2006).Fig. 5. Analysis of cell surface marker expression and gene expression in differentiatin
either in monolayer or in EB in the presence or absence of activin A, as noted. EpCAM
(middle and right columns, respectively) are shown for live, EpCAM+ cells. qPCR ex
Rbm35a, Tmprss2) and six visceral endoderm-specific genes (Afp, Amn, Hnf4a, Npa
EB in the presence or absence of activin A, as noted. qPCR expression for each gen
difference and the number of genes significantly upregulated are displayed for e
differentiated ES cell sample, the percentage of cells expressing visceral endoder
percentages in undifferentiated ES cells and plotted against the percentage of average
sets as compared to undifferentiated ES cells. A trendline has been added, and the cAs far as characterizing the “endoderm identity” cassette,
our microarray analysis of E8.25 endoderm isolated by three
distinct methods has confirmed a group of 22 genes as reliable
markers of E7.5–E9.5 endoderm (Table 3). These genes are
expressed in definitive and visceral endoderm, as the current
analysis did not reveal a set of genes expressed in all definitive
endoderm but not in extraembryonic endoderm. This list of
“endoderm signature” genes, as well as the list of visceral
endoderm-specific transcription factors and cell surface proteins
generated from the microarrays, provides a standard to which
ES-derived endoderm-like cells should be compared and will
provide an answer to whether current differentiation protocols
promote differentiation of ES cells into cells closely resembling
definitive endoderm or whether they merely allow for the
expression of a few select endodermal genes. Preliminary
analysis suggests that activin treatment, currently suggested to
promote endoderm formation from ES cells (Kubo et al., 2004;
Yasunaga et al., 2005), induces definitive endoderm gene
expression but inhibits visceral endoderm gene expression
(Supplemental Fig. 6). However, since the present gene
expression analysis only examined early embryonic timepoints,
determining which of the 22 genes are selectively expressed in
endoderm at all stages of development and which genes are
expressed more broadly later is important for interpreting
expression patterns in differentiating ES cells.
An additional objective of this work was to enable flow
cytometric prospective isolation of definitive and visceral
endoderm from embryos. Just as prospective isolation of adult
hematopoietic cell types paved the way for an impressive array
of therapeutic and research advances (reviewed in Shizuru et al.,
2005), flow cytometric isolation of embryo- and ES-derived cell
populations will be invaluable for evaluating developmental
potential and for eventually selecting purified cell types and
excluding tumorigenic ES cells for therapeutic applications.
The ability to prospectively isolate definitive endoderm,
visceral endoderm, mesoderm and other cell types from
mouse embryos using the antibodies described in this work
(Fig. 4P) opens avenues to investigate cell fate specification and
commitment.
Utilizing these surface markers to isolate specific popula-
tions from differentiating ES cells is also an exciting prospect.
In fact, statistical correlation of visceral endoderm-specific cell
surface marker expression and transcript expression suggests
that the markers utilized in this study allow for clear
distinction of ES cell-derived visceral endoderm. However,
this correlation analysis also suggests that the cell surface
marker profile that in E8.25 embryos is unique to definitive
endoderm does not predict ES cell-derived endodermg ES cells. Expression of cell surface markers in ES cells differentiated for 7 days
expression (left column) is shown for live cells, and CD38 and Dpp4 expression
pression averages of six endoderm signature genes (Cdcp1, FoxA1, Npnt, Rab15,
s2, Slc13a4, Tcf2) in ES cells differentiated for 7 days either in monolayer or in
e is normalized to expression in undifferentiated ES cells, and the average fold
ach condition and gene set. (C–D) Statistical correlation analysis. For each
m (C) or any endoderm (D) cell surface marker profile is normalized to the
qPCR gene induction of visceral endoderm (C) or endoderm signature (D) gene
orrelation coefficient is noted on the graph.
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unexpectedly large percentage of cells retain the surface
marker expression profile of undifferentiated ES cells
(EpCAM+CD38+Dpp4−) even after 7 days of induced
differentiation (Supplemental Fig. 6), even though this marker
profile is uncharacteristic of any cells within the E7.5–E9.5
mouse embryo (data not shown). This result suggests that
protein expression dynamics may differ in ES cell culture than
in embryos, which could be a result of differing cell adhesion
mechanisms in vitro as compared to in vivo or of a lack of
tight regulation of gene expression in ES cell culture. Thus,
prospective isolation of specific populations of cells from
differentiating ES cells will require not only an understanding
of marker expression in vivo but also careful comparison of
protein dynamics in vitro.
Although isolation of a pure population of ES cell-derived
definitive endoderm was not possible using the methods
presented in this study, a clear strategy for such isolation
comes from the microarray analysis. Among the “endoderm
signature” genes are several cell surface proteins specifically
enriched in E8.25 definitive and visceral endoderm and absent
in ES cells (Cacna1b, Cldn8, Npnt, Tmprss2). We are currently
engaged in an effort to produce flow cytometrically functional
antibodies to these proteins. These antibodies should be
valuable for purification and characterization of endoderm
differentiated from mouse and human ES cells.
One additional challenge of ES cell differentiation that this
work underscores involves timing. Germ layer tissue isolated
from different developmental stages has molecular differ-
ences: EpCAM is downregulated in neuroectoderm/notochord
gradually from E7.5 to E9.5, FE-J1 is only expressed in
endoderm from E7.5 to E8.25, and some genes isolated as
endodermally enriched at E8.25 are not enriched in all stages
between E7.5 and E9.5. These temporal changes no doubt
reflect underlying differences in cells from these develop-
mental stages, as is clearly manifested by the fact that distinct
anterior–posterior regions of the endoderm begin to express
organ-specific transcripts and proteins at E8.25 8–10 somite
stages (Deutsch et al., 2001; Serls et al., 2005) and display
pre-pattering prior to this time. In the embryo, unspecified
definitive endoderm exists only transiently, and it is unclear
whether these cells have an internal clock mechanism that
regulates assumption of organ-specific genes or whether early
definitive endoderm could be prevented from differentiating
if removed from its developmental context. Regardless,
attempts to differentiate ES cells into mature cell types
through germ layer intermediates must be attuned to issues of
timing and stage-specific gene expression, as competence to
respond to developmentally appropriate signals is likely to be
time-dependent.
This work represents a step forward in understanding the
nature of early definitive and visceral endoderm. The markers
identified will guide experiments aimed at understanding the
commitment of endoderm and its potency as the precursor of all
gut-derived organs. The data should also help direct experi-
ments aimed at ES cell differentiation into therapeutically
relevant endodermal derivatives.Acknowledgments
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